AI assistant
GlaxoSmithKline PLC — Director's Dealing 2014
Feb 26, 2014
5262_dirs_2014-02-26_3e478000-dd01-43ec-9ea3-e54d2f68c424.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0320B
GlaxoSmithKline PLC
26 February 2014
Notification of Transactions of Directors and Persons Discharging Managerial Responsibility
GlaxoSmithKline Share Value Plan
Sale of shares to meet tax liabilities
The table below sets out changes in the interests of Persons Discharging Managerial Responsibility (PDMR) in the Ordinary Shares of GlaxoSmithKline plc arising from the sales of Ordinary Shares at a fair market value price of £16.73 per Ordinary Share on 24 February 2014. These sales were to meet tax liabilities following the vesting of awards granted in 2011 under the GlaxoSmithKline Share Value Plan (SVP).
| Number of Ordinary Shares sold to meet tax liabilities following the vesting of a SVP award | |
| Mr R Connor | 3,869 |
| Mr P Thomson | 4,724 |
| Mrs V Whyte | 4,724 |
The table below sets out changes in the interests of a PDMR in the American Depositary Shares (ADS) of GlaxoSmithKline plc arising from the withholding of ADSs at a fair market value price of $55.69 per ADS on 24 February 2014 to meet tax liabilities following the vesting of awards granted in 2011 under the SVP.
| Number of ADSs withheld to meet tax liabilities following the vesting of a SVP award | |
| Mr J Ford | 2,276 |
The Company and PDMRs were advised of these transactions on 25 February 2014.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Sonja Arsenić
Corporate Secretariat
26 February 2014
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSQQLFLZLFEBBF